The University has secured funding from the Medical Research Council (MRC) for a new Manchester Single Cell Research Centre (SCRC). The £5 million award application was led by Faculty scientist Professor Cay Kielty in collaboration with colleagues from FLS and the Faculty of Medical and Human Sciences.
Researchers in the SCRC will focus on characterising a group of rare cells called circulating tumour cells (CTCs), which give rise to drug-resistant cancers. They will also be working on specific stem cells that can enable the regeneration of damaged tissues such as muscle, joints, skin, and blood vessels. Professor Kielty says:
“This new technology will enable us to define cell heterogeneity and the biology of rare cells in health and disease.”